2021 MedCan Speaker

Peter Crock

Chief Executive Officer,
Cann Group

Drawing on nearly three decades experience at global agribusiness Nufarm (ASX: NUF), and as the founding Chairman of MCIA, Cann Group’s CEO Peter Crock is shaping the future of the medicinal cannabis industry in Australia. With Peter at the helm and working closely with an experienced board of directors, Cann Group (ASX: CAN) received the first commercial cultivation licence in Australia, and was the first medicinal cannabis company to successfully list via an Initial Public Offering (IPO) on the Australian Securities Exchange (ASX), raising AUD$13.5 million.

To accelerate its growth, Cann Group has completed subsequent capital raisings totalling more than AUD$125m, which has enabled the advancement of its’ most ambitious project to date; a controlled environment, automated production facility which will be capable of producing up to 70,000kg of medicinal cannabis products per year when at full capacity.

With deep knowledge and experience in the areas of marketing, business and technology development, as well as mergers and acquisitions, Peter has overseen the growth and advancement of Cann Group.
In chairing the MCIA, Australia’s peak industry body for medicinal cannabis, Peter is well versed in the management of regulatory framework in both Australia, and abroad.


All Sessions by Peter Crock

Day 1 - Industry Summit

Time Industry Stream
13:40
Industry
  • A glimpse into the journey of bringing a product in the market
  • The challenges and barriers faced in making this a reality
  • Specific challenges tackling different regulatory systems around the world
  • Breaking barriers in product to market strategies – what are the learnings?
  • The way forward

Peter Crock 
Chief Executive Officer, Cann Group

More Speakers

Kai Keli’iho’omalu

Cultivation Manager

Andrew Patterson

Business Commentator

Peter Crock

Chief Executive Officer

Bonni Goldstein

Medical Director